Literature DB >> 9210915

Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy.

D Harats1, R Pauzner, D Elstein, A Many, M W Klutstein, M R Kramer, Z Farfel, A Zimran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9210915     DOI： 10.1159/000203562

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  8 in total

Review 1.  Remaining problems in the management of patients with Gaucher disease.

Authors:  A Erikson
Journal:  J Inherit Metab Dis       Date:  2001       Impact factor: 4.982

2.  Outcome of ten years' echocardiographic follow-up in children with Gaucher disease.

Authors:  Dror Rosengarten; Aya Abrahamov; Amiram Nir; Benjamin Farber; Joram Glaser; Ari Zimran; Deborah Elstein
Journal:  Eur J Pediatr       Date:  2006-08-29       Impact factor: 3.183

3.  Echocardiographic Assessment of Left Ventricular Function in Type 1 Gaucher's Disease.

Authors:  Mirta Kozelj; Samo Zver; Vesna Zadnik
Journal:  Adv Hematol       Date:  2010-07-20

Review 4.  Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.

Authors:  Pramod K Mistry; Tamar Taddei; Stephan vom Dahl; Barry E Rosenbloom
Journal:  Crit Rev Oncog       Date:  2013

Review 5.  Gaucher disease and the clinical experience with substrate reduction therapy.

Authors:  Ari Zimran; Deborah Elstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

6.  Type I Gaucher disease with exophthalmos and pulmonary arteriovenous malformation.

Authors:  Chun-An Chen; Nelson L S Tang; Yin-Hsiu Chien; Wei-Min Zhang; Jou-Kou Wang; Wuh-Liang Hwu
Journal:  BMC Med Genet       Date:  2005-06-09       Impact factor: 2.103

7.  Reversal of life-threatening hepatopulmonary syndrome in Gaucher disease by imiglucerase enzyme replacement therapy.

Authors:  Amal El Beshlawy; Vagishwari Murugesan; Pramod Kumar Mistry; Khaled Eid
Journal:  Mol Genet Metab Rep       Date:  2019-06-28

Review 8.  Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension.

Authors:  Mazen Al-Qadi; Barbara LeVarge; H James Ford
Journal:  Front Med (Lausanne)       Date:  2021-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.